Rojek, Alexandra E.
Smith, Sonali M. http://orcid.org/0000-0002-9893-4949
Article History
Received: 19 July 2021
Revised: 4 November 2021
Accepted: 24 November 2021
First Online: 24 February 2022
Competing interests
: A.E.R. has no competing interests to report. S.M.S. has no competing interests related to this work. There was no funding from any sources for this work. Per ICJME guidelines, S.M.S. has served as a consultant for ADC Therapeutics, Gilead, BMS, Morphosys, Janssen, Karyopharm, Genentech, TGTX, Celgene, Bayer.